GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $964,048 | -37.9% | 341,861 | -10.4% | 0.00% | -40.0% |
Q1 2024 | $1,553,360 | +241.3% | 381,661 | +38.4% | 0.01% | +150.0% |
Q4 2023 | $455,126 | +80.9% | 275,834 | +315.6% | 0.00% | +100.0% |
Q3 2023 | $251,550 | -31.1% | 66,372 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $365,046 | +32.3% | 66,372 | +3.4% | 0.00% | 0.0% |
Q1 2023 | $275,940 | +7.5% | 64,172 | -1.8% | 0.00% | 0.0% |
Q4 2022 | $256,755 | -26.0% | 65,332 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $347,000 | -19.1% | 65,332 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $429,000 | -14.5% | 65,332 | -4.5% | 0.00% | 0.0% |
Q1 2022 | $502,000 | +232.5% | 68,392 | +221.6% | 0.00% | +100.0% |
Q4 2021 | $151,000 | -71.7% | 21,269 | -0.2% | 0.00% | -50.0% |
Q3 2021 | $534,000 | -38.8% | 21,312 | -34.3% | 0.00% | -50.0% |
Q2 2021 | $873,000 | -6.4% | 32,442 | -1.1% | 0.00% | 0.0% |
Q1 2021 | $933,000 | – | 32,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,279,484 | $35,601,781 | 4.82% |
GREAT POINT PARTNERS LLC | 1,022,537 | $4,396,909 | 0.86% |
Artal Group S.A. | 2,814,191 | $12,101 | 0.72% |
PFM Health Sciences, LP | 2,648,297 | $11,387,677 | 0.50% |
SVB FINANCIAL GROUP | 40,401 | $173,724 | 0.33% |
SECTORAL ASSET MANAGEMENT INC | 385,070 | $1,655,801 | 0.32% |
Yiheng Capital Management, L.P. | 1,601,766 | $6,887,594 | 0.27% |
EcoR1 Capital, LLC | 1,956,579 | $8,413,290 | 0.27% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,194,522 | 0.23% |
Bellevue Group AG | 3,620,280 | $15,567,204 | 0.23% |